A
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
Price:
3.42
THB
3.64%
Market Closed
Market Cap:
฿1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Asia Medical & Agricultural Laboratory & Research Center PCL
SET:AMARC
|
TH |
|
O
|
Orocobre Ltd
LSE:0TWH
|
AU |
|
Cytosorbents Corp
NASDAQ:CTSO
|
US |
|
Tsodilo Resources Ltd
XTSX:TSD
|
CA |
|
Yonyou Network Technology Co Ltd
SSE:600588
|
CN |
|
C
|
Chow Steel Industries PCL
SET:CHOW
|
TH |
|
Beijer Alma AB
STO:BEIA B
|
SE |
|
S
|
Super Tool Co Ltd
TSE:5990
|
JP |
|
G
|
Gapwaves AB
STO:GAPW B
|
SE |
|
T
|
TPI Polene PCL
SET:TPIPL
|
TH |
Balance Sheet
Balance Sheet Decomposition
Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical & Agricultural Laboratory & Research Center PCL
Balance Sheet Decomposition is not available for
Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical & Agricultural Laboratory & Research Center PCL
Balance Sheet
Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical & Agricultural Laboratory & Research Center PCL
Currency: THB
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
3
|
2
|
3
|
47
|
33
|
30
|
46
|
|
| Cash Equivalents |
1
|
3
|
2
|
3
|
47
|
33
|
30
|
46
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
180
|
90
|
80
|
140
|
|
| Total Receivables |
35
|
39
|
52
|
52
|
51
|
62
|
73
|
60
|
|
| Accounts Receivables |
35
|
39
|
52
|
52
|
51
|
62
|
73
|
59
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Inventory |
9
|
8
|
8
|
8
|
12
|
10
|
11
|
13
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Current Assets |
45
|
51
|
62
|
63
|
291
|
195
|
194
|
262
|
|
| PP&E Net |
119
|
137
|
309
|
340
|
361
|
394
|
382
|
387
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
387
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
263
|
|
| Intangible Assets |
29
|
28
|
23
|
21
|
21
|
21
|
23
|
23
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
10
|
10
|
0
|
|
| Other Long-Term Assets |
19
|
64
|
23
|
24
|
27
|
28
|
33
|
33
|
|
| Total Assets |
212
N/A
|
279
+32%
|
417
+49%
|
448
+7%
|
699
+56%
|
649
-7%
|
642
-1%
|
705
+10%
|
|
| Liabilities | |||||||||
| Accounts Payable |
14
|
16
|
19
|
26
|
25
|
28
|
36
|
9
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
|
| Short-Term Debt |
19
|
6
|
8
|
8
|
4
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
12
|
17
|
34
|
41
|
31
|
31
|
21
|
12
|
|
| Other Current Liabilities |
2
|
3
|
4
|
16
|
6
|
6
|
13
|
10
|
|
| Total Current Liabilities |
47
|
42
|
65
|
92
|
66
|
66
|
70
|
55
|
|
| Long-Term Debt |
43
|
48
|
142
|
124
|
60
|
38
|
17
|
9
|
|
| Deferred Income Tax |
6
|
6
|
7
|
10
|
13
|
16
|
16
|
14
|
|
| Other Liabilities |
4
|
7
|
10
|
11
|
12
|
15
|
17
|
25
|
|
| Total Liabilities |
100
N/A
|
103
+2%
|
224
+118%
|
236
+6%
|
151
-36%
|
134
-11%
|
120
-10%
|
103
-14%
|
|
| Equity | |||||||||
| Common Stock |
100
|
150
|
150
|
150
|
210
|
210
|
210
|
210
|
|
| Retained Earnings |
12
|
27
|
44
|
62
|
62
|
28
|
35
|
116
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
276
|
276
|
276
|
276
|
|
| Total Equity |
112
N/A
|
177
+58%
|
194
+10%
|
212
+9%
|
548
+159%
|
514
-6%
|
521
+1%
|
602
+16%
|
|
| Total Liabilities & Equity |
212
N/A
|
279
+32%
|
417
+49%
|
448
+7%
|
699
+56%
|
649
-7%
|
642
-1%
|
705
+10%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
120
|
120
|
120
|
420
|
420
|
420
|
420
|
420
|
|
Switch to:
Switch to:
See Also
Discover More
